| Indolactam V | Ki | 137.9 [1], 212.6 [2] |
| Staurosporine | IC50 | 59.0 [1] |
| Balanol | IC50 | 10.0 [1], 20.0 [2], 30.0 [3], 34.0 [4] |
| 8-Octyl-benzolactam-V9 | Ki | 5200.0 [1], 10000.0 [2] |
| 8-Decyl-5-hydroxymethyl-2-isopropyl-1-methyl-1,2,5,6-tetrahydro-benzo[e][1,4]oxazocin-3-one | Ki | 6320.0 [1], 6321.0 [2], 17574.0 [3], 17600.0 [4] |
| 2-[2,6-Dihydroxy-4-[3-[(4-hydroxybenzoyl)amino]azepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 10.0 [1], 30.0 [2], 140.0 [3] |
| Balanol analog 4 | IC50 | 12.0 [1], 13.0 [2] |
| Balanol analog 5 | IC50 | 10.0 [1] |
| Ruboxistaurin | IC50 | 300.0 [1] |
| (2S,5S)-8-Decyl-5-(hydroxymethyl)-1-methyl-2-propan-2-yl-2,4,5,6-tetrahydro-1,4-benzodiazocin-3-one | Ki | 140.0 [1], 150.6 [2], 1664.0 [3] |
| Phorbol 12,13-dibutyrate | Ki | 1.58 [1], 2.91 [2] |
| Enzastaurin | IC50 | 83.0 [1], 2000.0 [2] |
| (2S)-1-(1H-Indol-3-yl)-3-(5-isoquinolin-6-ylpyridin-3-yl)oxy-propan-2-amine | IC50 | 270.0 [1] |
| 8-Dec-1-ynyl-5-hydroxymethyl-2-isopropyl-1-methyl-1,4,5,6-tetrahydro-2H-benzo[e][1,4]diazocin-3-one | Ki | 40.7 [1], 43.0 [2] |
| (1S,3R,5R,9R,13R)-9-(Hydroxymethyl)-3-[4-(3-hydroxyphenyl)butyl]-16,16-dimethyl-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 39.0 [1] |
| 2-[2,6-Dihydroxy-4-[2-[(4-hydroxybenzoyl)amino]cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 10.0 [1] |
| 5-Hydroxymethyl-2-isopropyl-1-undecyl-1,2,5,6-tetrahydro-benzo[e][1,4]oxazocin-3-one | Ki | 2820.0 [1], 5750.0 [2] |
| [(1R,3S,7S,8E,11S,12S,13E,17R,21R,23S)-11,21-Dihydroxy-17-[(1R)-1-hydroxyethyl]-13-(2-methoxy-2-oxoethylidene)-10,10-dimethyl-19-oxo-6,18,27,28,29-pentaoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] octanoate | Ki | 500.0 [1] |
| (10S,13S)-13-(Hydroxymethyl)-9-methyl-10-propan-2-yl-3,9,12-triazatricyclo[6.6.1.04,15]pentadeca-1,4(15),5,7-tetraene-11-thione | Ki | 288.1 [1], 295.7 [2] |
| 7-Decyl-5-hydroxymethyl-2-isopropyl-1-methyl-1,2,5,6-tetrahydro-benzo[e][1,4]oxazocin-3-one | Ki | 970.0 [1], 1720.0 [2] |
| 9-Decyl-5-hydroxymethyl-2-isopropyl-1-methyl-1,2,5,6-tetrahydro-benzo[e][1,4]oxazocin-3-one | Ki | 675.0 [1], 2360.0 [2] |
| 1-Hexylindolactam-V | Ki | 15.0 [1], 39.0 [2] |
| 2-[2,6-Dihydroxy-4-[[2-[(4-hydroxybenzoyl)amino]-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]oxycarbonyl]benzoyl]-3-hydroxybenzoic acid | IC50 | 4600.0 [1] |
| (3S,6S)-11-Hexyl-6-(hydroxymethyl)-2-methyl-3-propan-2-yl-2,5,11-triazatricyclo[7.6.1.012,16]hexadeca-1(15),9,12(16),13-tetraen-4-one | Ki | 420.0 [1], 11000.0 [2] |
| [2-(Hydroxymethyl)-5-oxo-4-propan-2-ylideneoxolan-2-yl]methyl 3-[4-[2-(4-methylphenyl)ethynyl]phenoxy]propanoate | Ki | 35.0 [1], 78.0 [2] |
| [2-(Hydroxymethyl)-5-oxo-4-propan-2-ylideneoxolan-2-yl]methyl 2-[4-[2-(4-methylphenyl)ethynyl]phenoxy]acetate | Ki | 50.8 [1], 139.6 [2] |
| [2-(Hydroxymethyl)-5-oxo-4-propan-2-ylideneoxolan-2-yl]methyl 4-[4-[2-(4-methylphenyl)ethynyl]phenoxy]butanoate | Ki | 12.3 [1], 31.7 [2] |
| [2-(Hydroxymethyl)-5-oxo-4-propan-2-ylideneoxolan-2-yl]methyl 4-[2-(4-methylphenyl)ethynyl]benzoate | Ki | 6.2 [1], 15.7 [2] |
| [(1R,3S,7S,8E,11S,12S,13E,17R,21S,23S)-11,21-Dihydroxy-17-[(1R)-1-hydroxyethyl]-13-(2-methoxy-2-oxoethylidene)-10,10-dimethyl-19-oxo-6,18,27,28,29-pentaoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] octanoate | Ki | 500.0 [1] |
| [(1S,3E,5S,9S,11S,15R,19R,23E,24S)-11-Tert-butyl-1,15-dihydroxy-19-[(1R)-1-hydroxyethyl]-23-(2-methoxy-2-oxoethylidene)-2,2-dimethyl-17-oxo-6,12,18,25,26-pentaoxatricyclo[19.3.1.15,9]hexacos-3-en-24-yl] octanoate | Ki | 500.0 [1] |
| [2-[(4-Hydroxyphenyl)methyl]cyclopentyl] 3,5-dihydroxy-4-(2-hydroxy-6-methoxycarbonylbenzoyl)benzoate | IC50 | 1700.0 [1] |
| 2-[2,6-Dihydroxy-4-[2-[(4-hydroxyphenyl)methyl]cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 130.0 [1] |
| 2-[2,6-Dihydroxy-4-[2-(4-hydroxyphenoxy)cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 250.0 [1] |
| 2-[2,6-Dihydroxy-4-[4-[(4-hydroxyphenyl)methyl]pyrrolidin-3-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 5.0 [1], 40.0 [2] |
| [4-[(4-Hydroxyphenyl)methyl]pyrrolidin-3-yl] 3,5-dihydroxy-4-(2-hydroxy-6-methoxycarbonylbenzoyl)benzoate | IC50 | 380.0 [1] |
| [(1R,2R,6S,10S,11R,13S,14R,15R)-13-Butanoyloxy-1-hydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] butanoate | Ki | 1.84 [1], 5.23 [2] |
| (9S,12S)-12-(Hydroxymethyl)-8-methyl-9-propan-2-yl-3-(trifluoromethyl)-1,2,8,11-tetrazatetracyclo[12.2.1.04,16.07,15]heptadeca-2,4(16),5,7(15),14(17)-pentaen-10-one | Ki | 234.0 [1], 1100.0 [2] |
| (9S,12S)-12-(Hydroxymethyl)-3,8-dimethyl-9-propan-2-yl-1,2,8,11-tetrazatetracyclo[12.2.1.04,16.07,15]heptadeca-2,4(16),5,7(15),14(17)-pentaen-10-one | Ki | 1510.0 [1], 2580.0 [2] |
| (9S,12S)-12-(Hydroxymethyl)-8-methyl-9-propan-2-yl-1,2,8,11-tetrazatetracyclo[12.2.1.04,16.07,15]heptadeca-2,4(16),5,7(15),14(17)-pentaen-10-one | Ki | 61.3 [1], 225.0 [2] |
| 2-[2,6-Dihydroxy-4-[(1R,2R)-2-[(4-hydroxybenzoyl)amino]cycloheptyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 60.0 [1] |
| Balanol analog 3 | IC50 | 2200.0 [1] |
| 2-[2,6-Dihydroxy-4-[(3R)-3-[(4-hydroxybenzoyl)amino]azepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 10.0 [1], 34.0 [2] |
| Phorbol 12-myristate 13-acetate | Ki | 4.9 [1] |
| Bisindolylmaleimide i | IC50 | 30.0 [1] |
| Go-6976 | IC50 | 2.0 [1] |
| Doramapimod | IC50 | 30000.0 [1] |
| Purvalanol B | IC50 | 100000.0 [1] |
| Purvalanol A | IC50 | 10000.0 [1] |
| Sns-032 | IC50 | 40000.0 [1] |
| Aplysiatoxin | Ki | 0.63 [1] |
| Debromoaplysiatoxin | Ki | 0.38 [1] |
| Cercosporamide | IC50 | 5800.0 [1] |
| A-674563 | Ki | 1200.0 [1] |
| Rac-syn-Balanol | IC50 | 34.0 [1] |
| 4-(7-Butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol | IC50 | 100000.0 [1] |
| 1-(Tert-Butyl)-3-(naphthalen-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 100000.0 [1] |
| Hbdde | IC50 | 50000.0 [1] |
| 7-Octylindolactam V | Ki | 1.2 [1] |
| CID 59604787 | IC50 | 10000.0 [1] |
| PKCbeta Inhibitor | IC50 | 1000.0 [1] |
| Benzolactam-V8 | Ki | 3100.0 [1] |
| (3Z)-6-(4-Hydroxy-3-methoxyphenyl)-3-(1H-pyrrol-2-ylmethylene)-1,3-dihydro-2H-indol-2-one | IC50 | 50000.0 [1] |
| (2R)-2-[(2S)-4-[3-Chloro-5-fluoro-6-(2H-pyrazolo[3,4-b]pyridin-3-yl)pyridin-2-yl]piperazin-2-yl]-3-methylbutan-2-ol | Ki | 725.0 [1] |
| 17,20,23-Trioxa-4,12,14,26,28-pentazahexacyclo[24.6.1.17,14.02,6.08,13.027,32]tetratriaconta-1(33),2(6),7(34),8(13),9,11,27(32),28,30-nonaene-3,5-dione | IC50 | 10000.0 [1] |
| Indolylylmaleimide 1 | IC50 | 1340.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)acetamide | Ki | 8800.0 [1] |
| 3-(4'-Hydroxybiphenyl-4-Yl)-N-(4-Hydroxycyclohexyl)-1,4-Dihydroindeno[1,2-C]pyrazole-6-Carboxamide | IC50 | 33000.0 [1] |
| 4-Amino-5-chloro-6-ethoxy-pyridine-2-carboxylic acid 4-methanesulfonyl-benzylamide | Ki | 8800.0 [1] |
| 7-Chloro-3-oxo-8-(1,3-thiazol-5-ylmethylamino)-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5,7,9,17(21),18-hexaene-18-carbonitrile | Ki | 8750.0 [1] |
| 1-({4-[(3,4-Dichlorophenyl)methoxy]phenyl}methyl)azetidine-3-carboxylic acid | IC50 | 10000.0 [1] |
| 3-[[5-[6-[(3-Chlorophenyl)amino]pyrazinyl]-3-pyridinyl]amino]-1-propanol | IC50 | 10000.0 [1] |
| (1S)-2-(1H-Indol-3-YL)-1-[({5-[(E)-2-pyridin-4-ylvinyl]pyridin-3-YL}oxy)methyl]ethylamine | IC50 | 1200.0 [1] |
| 3,13-Diazahexacyclo[14.8.0.02,10.04,9.011,15.017,22]tetracosa-1(16),2(10),4,6,8,11(15),17,19,21,23-decaene-12,14-dione | IC50 | 56500.0 [1] |
| Indolylylmaleimide 2 | IC50 | 1200.0 [1] |
| Meridianin E | IC50 | 2000.0 [1] |
| Betulinic acid 3-O-benzoate | IC50 | 74000.0 [1] |
| 17,20,23,26-Tetraoxa-4,12,14,29,31-pentazahexacyclo[27.6.1.17,14.02,6.08,13.030,35]heptatriaconta-1(36),2(6),7(37),8(13),9,11,30(35),31,33-nonaene-3,5-dione | IC50 | 10000.0 [1] |
| 20-Ethyl-17,23-dioxa-4,14,20,26-tetrazahexacyclo[24.6.1.17,14.02,6.08,13.027,32]tetratriaconta-1(33),2(6),7(34),8,10,12,27,29,31-nonaene-3,5-dione | IC50 | 300.0 [1] |
| 6-{5-[(2S)-2-Amino-3-(1H-indol-3-yl)propoxy]-2-chloropyridin-3-yl}isoquinoline | IC50 | 540.0 [1] |
| 7-Chloro-8-(3-hydroxypropoxy)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaene-19-carbonitrile | Ki | 10000.0 [1] |
| 7-Chloro-8-(3-hydroxypropyl)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile | Ki | 10000.0 [1] |
| N-(7-Chloro-19-cyano-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaen-8-yl)methanesulfonamide | Ki | 10000.0 [1] |
| 3-(1-Methyl-1H-indol-3-yl)-4-(1-piperidin-4-yl-1H-indol-3-yl)-pyrrole-2,5-dione | IC50 | 2000.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)-2-(2,5-dimethoxy-4-methylsulfonylphenyl)acetamide | Ki | 8800.0 [1] |
| N-(4-Amino-5-chloro-6-ethoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 8800.0 [1] |
| N-(4-Amino-5-cyano-6-isopropoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 8800.0 [1] |
| N-(4-Amino-5-cyano-6-phenylpyridin-2-yl)acetamide | Ki | 8800.0 [1] |
| 6-{5-[(2S)-2-Amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}isoquinolin-3-amine | IC50 | 31.0 [1] |
| (13R,15S)-13-Methyl-16-oxa-8,9,12,22,24-pentazahexacyclo[15.6.2.16,9.112,15.02,7.021,25]heptacosa-1(24),2,4,6,17,19,21(25)-heptaene-23,27-dione | IC50 | 1000.0 [1] |
| 17,23-Dimethyl-20-oxa-4,14,17,23,26-pentazahexacyclo[24.6.1.17,14.02,6.08,13.027,32]tetratriaconta-1(33),2(6),7(34),8,10,12,27,29,31-nonaene-3,5-dione | IC50 | 1560.0 [1] |
| 5,7-Dihydro-1,2,3,9,10,11-hexahydroxydibenz(c,e)oxepin | IC50 | 30000.0 [1] |
| 7-Chloro-9-ethyl-6-hydroxy-1H,3H,4H,9H-quinolino[2,3-c][1,2]oxazole-3,4-dione | Ki | 8750.0 [1] |
| 5-(2-Aminoethyl)-7-(7-(benzo[b]thiophen-2-yl)-1H-indazol-5-yl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine | IC50 | 1100.0 [1] |
| N-[3-[5-[2-(3-Morpholin-4-ylanilino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-phenylacetamide | IC50 | 1000.0 [1] |
| (1S,3R,5R,9R,13R)-9-(Hydroxymethyl)-16,16-dimethyl-3-(4-phenylbutyl)-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 80.0 [1] |
| 1-[5-Tert-butyl-3-[4-[2-(dimethylamino)ethyl]-5-oxo-1,4-diazepane-1-carbonyl]thiophen-2-yl]-3-(2,3-dichlorophenyl)urea | IC50 | 30000.0 [1] |
| (1R,3R,4R,5S,9R,13R)-9-(Hydroxymethyl)-3-[4-(3-hydroxyphenyl)butyl]-4,16,16-trimethyl-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 5.5 [1] |
| Acyclic Balanol Analog 16b | IC50 | 2700.0 [1] |
| 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
| 3-[1-(1-Benzylpiperidin-4-yl)indol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione | IC50 | 7000.0 [1] |